Clinical Trial Update: Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

View source ↗

Summary

The clinical trial evaluates the Intracept minimally invasive procedure for vertebrogenic back pain and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Vertebrogenic Pain Syndrome

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Chronic Low-back Pain, Vertebrogenic Pain Syndrome | Status: RECRUITING